Bank Julius Baer & Co. Ltd, Zurich Crispr Therapeutics Ag Transaction History

Bank Julius Baer & Co. Ltd, Zurich

  • $25.6 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
SELL
$38.62 - $72.18 $761,818 - $1.42 Million
-19,726 Reduced 99.35%
130 $8,000
Q3 2023

Nov 13, 2023
BUY
$45.39 - $59.0 $608,997 - $791,603
13,417 Added 208.37%
19,856 $901,000
Q2 2023

Jul 20, 2023
BUY
$43.47 - $67.77 $223,305 - $348,134
5,137 Added 394.55%
6,439 $361,000
Q1 2023

May 11, 2023
BUY
$41.0 - $56.12 $14,145 - $19,361
345 Added 36.05%
1,302 $59,000
Q4 2022

Jan 24, 2023
SELL
$39.19 - $65.67 $568,215 - $952,149
-14,499 Reduced 93.81%
957 $39,000
Q3 2022

Nov 04, 2022
BUY
$61.1 - $83.78 $9,409 - $12,902
154 Added 1.01%
15,456 $1.01 Million
Q2 2022

Jul 22, 2022
BUY
$43.23 - $73.83 $24,424 - $41,713
565 Added 3.83%
15,302 $930,000
Q1 2022

May 09, 2022
BUY
$53.19 - $79.24 $598,547 - $891,687
11,253 Added 322.99%
14,737 $925,000
Q4 2021

Feb 15, 2022
BUY
$70.09 - $111.29 $244,193 - $387,734
3,484 New
3,484 $264,000
Q1 2021

May 10, 2021
SELL
$110.72 - $210.04 $1.12 Million - $2.12 Million
-10,084 Closed
0 $0
Q4 2020

Feb 24, 2021
BUY
$79.67 - $173.23 $40,392 - $87,827
507 Added 5.29%
10,084 $1.54 Million
Q4 2020

Feb 12, 2021
BUY
$79.67 - $173.23 $762,999 - $1.66 Million
9,577 New
9,577 $1.54 Million

Others Institutions Holding CRSP

# of Institutions
491
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email